Dr Damien Kee
Honorary (Fellow)
Department of Medical Biology (WEHI)
113 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Translating ctDNA into cutaneous melanoma care: An international expert survey
DOI: 10.1016/j.ejca.2026.1166762026
Journal article
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial.
DOI: 10.1158/1078-0432.CCR-25-40092026
Journal article
Nivolumab and Ipilimumab in Advanced Mismatch Repair–Deficient/Microsatellite Instability–High Noncolorectal Cancers: A Nonrandomized Clinical Trial
DOI: 10.1001/jamaoncol.2025.47212026
Journal article
Systemic Surveillance Guidelines for Uveal Melanoma: A Systematic Review
DOI: 10.1111/ceo.700022026
Journal article
Genomic Therapy Matching in Rare and Refractory Cancers
DOI: 10.1001/jamaoncol.2026.01272025
Journal article
Uncertainty and hope in people with metastatic uveal melanoma in the era of immunotherapy and targeted treatments: a theory-based qualitative study
DOI: 10.1186/s12885-025-14368-62023
Research grants (ARC, NHMRC, MRFF)
Using Real World Data to Drive Cancer Care Research and Delivery
RECENT SCHOLARLY WORKS
2025
Journal article
797P Real-world experience of liquid biopsy (LBx) vs tissue-based comprehensive genomic profiling (tCGP)
DOI: 10.1016/j.annonc.2025.10.12112025
Journal article
768P Operational challenges of molecular tumour board (MTBs) in the Australasian public healthcare services: A scoping survey to inform the future of precision oncology
DOI: 10.1016/j.annonc.2025.10.11832025
Journal article
777P HIF2α pathway aberrations across tumour types: A rare but actionable entity with high germline conversion
DOI: 10.1016/j.annonc.2025.10.11922025
Journal article
1645P A phase Ib study to evaluate the safety, tolerability and efficacy of the combination of encorafenib, binimetinib and palbociclib in patients with BRAF-mutant metastatic melanoma (CELEBRATE)
DOI: 10.1016/j.annonc.2025.08.2273